Suspected primary brain tumour
ACR AC Brain Tumors (2025 rev)Contrast-enhanced MRI with a standardised tumour protocol, because the request is simultaneously a diagnostic question and the first step of a surgical plan, and a non-standard baseline compromises every follow-up study that comes after it.
Progressive focal deficit, personality change, new seizures with a focal onset, or a mass already seen on a CT performed for another reason.
Referenced decision support — confirm against your local protocol.
Decision support, not a directive. Protocols and timings shown are typical published ones — your local protocol takes precedence, and the vetting radiologist decides.
- Three things decide management here and only MRI provides them: the extent of non-enhancing infiltration on FLAIR, which usually exceeds the enhancing component and defines the resection target; the relationship of the lesion to eloquent cortex and white matter tracts; and the enhancement pattern with diffusion characteristics that separate high-grade tumour from abscess, lymphoma and demyelination. A standardised acquisition also becomes the measurable baseline against which every subsequent response assessment is made.
Nothing needs resolving before this goes ahead. Routine checks below are owned downstream.
How was this decided?
- pathwayadult — Adults
- rulerule-mr-device-screening — MR safety screening for implants and foreign bodies; checked by Radiographer at the scanner
- rulerule-contrast-reaction-premed — Prior contrast reaction and elective premedication; checked by Nurse before the scan
- rulerule-gadolinium-renal — Kidney function and gadolinium-based contrast; checked by Radiographer at the scanner
- rulerule-paeds-sedation — Sedation or anaesthesia for a child; checked by Nurse before the scan
- rulerule-pregnancy-gadolinium — Gadolinium in known or possible pregnancy; checked by Radiographer at the scanner
- rulerule-iv-access — Intravenous access adequate for the planned injection; checked by Radiographer at the scanner
Decision support only. Local protocol takes precedence.
Handled at the scanner(2)nothing for you to do
Settled and owned downstream. Each returns to a radiologist only on the stated trigger.
- MR safety screening for implants and foreign bodiesComplete the MR safety questionnaire, verify implant labelling and its stated conditions of use against this scanner and this protocol, and ensure no ferromagnetic object enters Zone IV.Radiographer at the scannerBefore the scanFlags back if: An implant or retained foreign body that is MR Unsafe, unlabelled, or cannot be identified; or an MR Conditional device whose stated conditions this scanner or the requested protocol cannot satisfy; or a credible unexcluded intraocular metallic foreign body history.
- Intravenous access adequate for the planned injectionSite and test a cannula that supports the protocol flow rate, preferring an antecubital or large forearm vein, and observe the injection for extravasation. A 20-gauge or larger cannula is preferred for flow rates of 3 mL/s or more.Radiographer at the scannerAt the scannerFlags back if: No cannula can be sited that supports the protocol flow rate — for example only a 22-gauge hand or foot cannula for a CT angiogram needing 4–5 mL/s; or the only available access is a central line or port that is not labelled power-injectable; or an extravasation occurs.
Pathways
Big forks are separate pathways; the first whose conditions match is the one used.
Deficit of hours, or a depressed conscious level — CT first
| Role | Study & protocol | Why this answers the question |
|---|---|---|
| First line | CT Head CT Head — Unenhanced usually appropriate | A tumour presents over weeks; a deficit measured in hours is a vascular event until proved otherwise, and a falling conscious level is mass effect, hydrocephalus or haemorrhage into a lesion. All three are questions an unenhanced CT answers in seconds and a twenty-minute tumour protocol answers too late — and the immediate decisions that follow, steroids, a neurosurgical call, transfer, are made on the CT. It does not replace the MRI: it establishes that there is time to do it properly. |
| Second line | MRI Brain MRI Brain — tumour protocol | Unchanged in content and deferred by a few hours: the standardised tumour protocol is still what maps non-enhancing infiltration on FLAIR, relates the lesion to eloquent cortex and gives the measurable baseline every later response assessment is compared against. Acquiring it once the patient is stable is what protects that baseline from a motion-degraded emergency acquisition. |
Adults
Matches your inputsDefault| Role | Study & protocol | Why this answers the question |
|---|---|---|
| First line | MRI Brain MRI Brain — tumour protocol usually appropriate | Three things decide management here and only MRI provides them: the extent of non-enhancing infiltration on FLAIR, which usually exceeds the enhancing component and defines the resection target; the relationship of the lesion to eloquent cortex and white matter tracts; and the enhancement pattern with diffusion characteristics that separate high-grade tumour from abscess, lymphoma and demyelination. A standardised acquisition also becomes the measurable baseline against which every subsequent response assessment is made. |
| Second line | CT Head CT Head — Unenhanced | The usual entry point rather than the answer. An unenhanced CT detects mass effect, hydrocephalus, calcification and haemorrhage within a lesion, and it is what triages a deteriorating patient to neurosurgery tonight. It cannot grade, cannot map infiltration and cannot plan a resection. |
Pitfalls
- Accepting an unenhanced MRI for a suspected tumour, which cannot characterise the lesion or plan surgery.
- Assuming enhancement equals high grade. A substantial proportion of low-grade gliomas enhance and some high-grade tumours do not.
- Missing lymphoma by imaging after corticosteroids have been started, which can make the lesion shrink and stop enhancing.
- Reporting a solitary lesion without diffusion, which is what separates an abscess from a necrotic tumour.
- Failing to flag suspected leptomeningeal spread, which requires whole-neuraxis coverage rather than a brain study alone.
Priors — what to pull first
- A stable appearance across years of prior imaging effectively excludes a high-grade tumour and reframes the lesion entirely.
- Where surgery has already occurred, the immediate post-operative study within the first 72 hours is the reference for residual disease; later enhancement is confounded by surgical granulation tissue.
What makes a good request
- If a lesion has already been seen on CT, say so and say where. The question becomes characterisation and surgical planning, which changes which sequences are essential.
- A standardised protocol matters beyond the first study: response assessment compares like with like, and a baseline acquired with ad hoc parameters cannot be measured against later scans.
- Perfusion and spectroscopy are problem-solving additions for grading and for separating tumour from treatment effect, not routine components of a first diagnostic study.
Scoring this once it is done
The classification and risk tools this question ends in.
How these studies are acquired
Contrast, phases and timing for every study on the pathways above.
Confirm locally
- MRI Brain — tumour protocol: timings are typical — confirm against local protocol.
- Timings, contrast volumes and rates above are typical published values. Your department's protocol, scanner and patient population decide the actual numbers.
- Safety thresholds and premedication policy follow local policy where it differs from the cited guidance.
References
- ACR Appropriateness Criteria — Brain Tumors · ACR Appropriateness Criteria
- American College of Radiology Manual on MR Safety: 2024 Update and Revisions. Radiology. · ACR MR Safety
- ACR Manual on MR Safety — zoning, MR Safe / MR Conditional / MR Unsafe labelling, and screening of patients and personnel · ACR MR Safety
- Safety of MRI in patients with cardiac implantable electronic devices — conditions of use, device interrogation and monitoring · Primary literature
- ACR Manual on Contrast Media — premedication regimens (elective oral prednisone 50 mg at 13/7/1 h plus diphenhydramine 50 mg at 1 h; methylprednisolone 32 mg at 12 and 2 h; accelerated IV hydrocortisone 200 mg or methylprednisolone 40 mg every 4 h; regimens under 4–5 h lack evidence of efficacy) · ACR Contrast Manual
- Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the ACR and the AAAAI. J Allergy Clin Immunol Pract, 2025. · Primary literature
- Schabelman E, Witting M. The relationship of radiocontrast, iodine and seafood allergies: a medical myth exposed. J Emerg Med. · Primary literature
- CAR/CSACI Practice Guidance for Contrast Media Hypersensitivity (2025) · Other
- Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the ACR and the National Kidney Foundation. — Group II NSF risk: 0 events in 4931 administrations at eGFR <30; upper 95% CI bounds 0.07% overall, 0.2% CKD 5D, 0.5% CKD 5 non-dialysis · ACR/NKF consensus
- Woolen SA et al. Risk of NSF in patients with stage 4 or 5 CKD receiving a group II GBCA: systematic review and meta-analysis. JAMA Intern Med. · Primary literature
- ESUR Contrast Media Guidelines v10.0 — gadolinium agents and NSF risk classification — European practice diverges: after the EMA Article 31 referral the marketing authorisations of several intravenous linear agents (gadodiamide, gadopentetate, gadoversetamide) were suspended, so the ACR "group I" discussion is largely moot in the EU/UK while remaining live in the US · ESUR
- EMA — gadolinium-containing contrast agents Article 31 referral: PRAC confirms restrictions on linear agents · Other
- AAP/AAPD Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures. Pediatrics 2019;143(6):e20191000. · Other
- Sedation and anaesthesia for imaging of the infant and neonate — a brief review (feed-and-wrap, fasting, monitoring) · Primary literature
- Image Gently — reducing the need for sedation through preparation and faster protocols in paediatric imaging · Image Gently
- Contrast Media in Pregnant and Lactating Patients — AJR Special Series on Contrast Media · Primary literature
- ACOG Committee Opinion — Guidelines for Diagnostic Imaging During Pregnancy and Lactation · Other
- ACR-SPR Practice Parameter for the Use of Intravascular Contrast Media · Other
- Behrendt FF et al. Peripheral intravenous power injection of iodinated contrast media through 22G and 20G cannulas: can high flow rates be achieved safely? A clinical feasibility study. · Primary literature
- Pressure injectors for radiologists: a review — extravasation incidence and catheter/flow-rate relationships · Primary literature
Implemented from the cited published sources. Educational and workflow support only; confirm against current guidelines and local policy before clinical use.